KR900017570A - 신규한 다공성 제약학적 형태 및 그의 제조방법 - Google Patents

신규한 다공성 제약학적 형태 및 그의 제조방법 Download PDF

Info

Publication number
KR900017570A
KR900017570A KR1019900007369A KR900007369A KR900017570A KR 900017570 A KR900017570 A KR 900017570A KR 1019900007369 A KR1019900007369 A KR 1019900007369A KR 900007369 A KR900007369 A KR 900007369A KR 900017570 A KR900017570 A KR 900017570A
Authority
KR
South Korea
Prior art keywords
paste
freeze
optionally
dried
pharmaceutical form
Prior art date
Application number
KR1019900007369A
Other languages
English (en)
Other versions
KR0163423B1 (ko
Inventor
꾸떠렐 프레더릭
반오이브 마갤리
Original Assignee
로우느-푸우랜크 상뜨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로우느-푸우랜크 상뜨 filed Critical 로우느-푸우랜크 상뜨
Publication of KR900017570A publication Critical patent/KR900017570A/ko
Application granted granted Critical
Publication of KR0163423B1 publication Critical patent/KR0163423B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Filtering Materials (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

내용 없음

Description

신규한 다공성 제약학적 형태 및 그의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. (a)하나 이상의 활성 물질, 시클로덱스트린, 및 임의로 포접을 용이하게 하기 위한 첨가제로 구성된 포접화합물; (b)적어도 하나의 희석제 및/또는 결합제; 및 (c)임의로 하나 이상의 향미제, 붕해제, 착색제 및/또는 안정제로 구성된, 균질한 외관의 다공성, 단위 동결-건조된 제약학적 형태.
  2. 제1항에 있어서, 활성 물질이 정진 자극제, 진통제, 항염제 또는 비타민인 제약학적 형태.
  3. 제2항에 있어서, 활성물질이 케토프로펜, 조피클론, 트리미프라민 페노바르비탈, 또는 비타민A인 제약학적 형태.
  4. 1)a)하나 이상의 활성 물질, 시크로덱스트린, 및 임의로 포접을 용이하게 하기 위한 첨가제로 구성된 포접화합물; (b)적어도 하나의 희석제 및/또는 결합제; 및 (c)임의로 하나 이상의 향미제, 붕해제, 착색제 및/또는 안정제및 페이스트의 점도를 요구되는 값으로 조절하기에 충분한 물을 함유한 페이스트를 제조하고; 2)페이스트를 단위량의 선결된 형태 및 부피로 분할 시키고, 3)페이스트를 동결-건조시키는 것으로 구성되고, 단, 상기조작2) 및 3)은 어느 하나의 순서로 수행될 수 있는 것으로 이해되는 균질한 외관의 다공성, 단위 동결-건조된 제약학적 형태를 제조하는 방법.
  5. 제4항에 있어서, 포접 화합물을 동결-건조될 페이스트의 제조전에 따로 제조하는 방법.
  6. 제4항에 있어서, 포접 화합물을 동결-건조될 페이스트의 제조동안 그 자리에서 제조하는 방법.
    ※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
KR1019900007369A 1989-05-24 1990-05-22 신규한 다공성 제약학적 형태 및 그의 제조방법 KR0163423B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR8906781A FR2647343B1 (fr) 1989-05-24 1989-05-24 Nouvelle forme pharmaceutique poreuse et sa preparation
FR8906.781 1989-05-24
FR8906781 1989-05-24

Publications (2)

Publication Number Publication Date
KR900017570A true KR900017570A (ko) 1990-12-19
KR0163423B1 KR0163423B1 (ko) 1998-12-01

Family

ID=9381955

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900007369A KR0163423B1 (ko) 1989-05-24 1990-05-22 신규한 다공성 제약학적 형태 및 그의 제조방법

Country Status (24)

Country Link
US (1) US5244881A (ko)
EP (2) EP0399902B1 (ko)
JP (1) JP2948271B2 (ko)
KR (1) KR0163423B1 (ko)
AT (2) ATE83663T1 (ko)
AU (2) AU631888B2 (ko)
CA (2) CA2017360A1 (ko)
DD (1) DD297915A5 (ko)
DE (2) DE69005359T2 (ko)
DK (2) DK0399902T3 (ko)
ES (2) ES2062437T3 (ko)
FI (1) FI103712B1 (ko)
FR (1) FR2647343B1 (ko)
GR (1) GR3006655T3 (ko)
IE (2) IE64370B1 (ko)
IL (2) IL94459A (ko)
NO (1) NO180517C (ko)
NZ (2) NZ233766A (ko)
PL (1) PL285327A1 (ko)
PT (2) PT94138B (ko)
TW (1) TW257672B (ko)
WO (1) WO1990014089A1 (ko)
YU (1) YU100790A (ko)
ZA (2) ZA903895B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1004318A3 (en) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Cyclodextrin composition
ATE172637T1 (de) 1991-12-24 1998-11-15 Yamanouchi Pharma Co Ltd Intrabukkal desintegrierende zubereitung und ihre herstellung
GB9318880D0 (en) * 1993-09-11 1993-10-27 Smithkline Beecham Plc Pharmaceutical composition
BR9507768A (pt) * 1994-05-27 1997-09-02 Farmarc Nederland Bv Composição farmacêutica
AU736912B2 (en) * 1997-02-20 2001-08-02 Therics, Inc. Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
BE1011251A3 (fr) 1997-07-03 1999-06-01 Ucb Sa Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
TW527195B (en) 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
CN100396276C (zh) * 1998-02-05 2008-06-25 诺瓦提斯公司 依普西龙组合物
IT1304190B1 (it) * 1998-12-18 2001-03-08 Euphar Group Srl Clatrati di deidroepiandrosterone e relative composizionifarmaceutiche
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
PL212123B1 (pl) 2002-01-15 2012-08-31 Ucb Farchim Sa Doustna kompozycja farmaceutyczna
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7351844B2 (en) 2002-02-25 2008-04-01 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
DE10239531A1 (de) * 2002-08-23 2004-03-04 Gulbins, Erich, Prof. Dr. Prophylaxe und Therapie von Infektionserkrankungen
DE10248314A1 (de) * 2002-10-16 2004-04-29 Dr. Suwelack Skin & Health Care Ag Verwendung von Formkörpern zur äußeren Anwendung
FR2876910B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant la mequitazine, une cyclodextrine et un agent d'interaction
JP2008531582A (ja) 2005-02-24 2008-08-14 ディフュージョン・ファーマシューティカルズ・エルエルシー トランスカロテノイド、それらの合成、配合、および使用
DE102005041860A1 (de) * 2005-09-02 2007-03-08 Schering Ag Nanopartikulärer Einschluss- und Ladungskomplex für pharmazeutische Formulierungen
EA200970944A1 (ru) 2007-04-13 2010-06-30 Диффьюжн Фармасьютикалз Ллс Применение биполярных транскаротиноидов в качестве предварительного лечения при лечении заболевания периферических сосудов
JP2009091309A (ja) * 2007-10-10 2009-04-30 Japan Organo Co Ltd バコパモニエラエキスを含有する組成物およびその製造方法ならびに飲食品
MX2010004803A (es) 2007-10-31 2010-09-09 Diffusion Pharmaceuticals Llc Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas.
WO2010028101A1 (en) * 2008-09-05 2010-03-11 Mcneil-Ppc, Inc. Method for making cetirizine tablets
CA2765697C (en) 2009-06-22 2019-11-12 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
EP2575487B1 (en) 2010-06-02 2017-10-18 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
SG10201507554RA (en) * 2010-09-13 2015-10-29 Bev Rx Inc Aqueous drug delivery system comprising off - flavor masking agent
RU2609198C1 (ru) * 2016-01-25 2017-01-30 Закрытое Акционерное Общество "БИОКОМ" Твердая лекарственная форма имипрамина немедленного высвобождения и способ ее получения
KR20230014850A (ko) 2016-03-24 2023-01-30 디퓨젼 파마슈티컬즈 엘엘씨 암을 치료하기 위한, 화학 요법 및 방사선 요법과의 양극성 트랜스 카로티노이드의 용도

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5443570B2 (ko) * 1972-10-27 1979-12-20
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
US4165382A (en) * 1977-10-17 1979-08-21 Jose Pozuelo Method of pharmacologically treating schizophrenia with alpha-methyl-para-tyrosine
US4349472A (en) * 1979-04-27 1982-09-14 Schering Corporation (S)-8(1-Adamantanecarbonyloxy)-7-chloro-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine
US4284555A (en) * 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4477378A (en) * 1980-02-05 1984-10-16 Schering Corp. Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
KR860700352A (ko) * 1984-11-27 1986-10-06 후지와라 도미오 2--(1-피페라지닐)-4-치환 페닐퀴놀린 유도체와 그 염의 제조방법
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition

Also Published As

Publication number Publication date
DD297915A5 (de) 1992-01-30
ES2054289T3 (es) 1994-08-01
DK0399903T3 (da) 1993-02-08
NO180517B (no) 1997-01-27
PL285327A1 (en) 1991-02-11
IE63317B1 (en) 1995-04-05
FR2647343B1 (fr) 1994-05-06
TW257672B (ko) 1995-09-21
EP0399903B1 (fr) 1992-12-23
NO902280D0 (no) 1990-05-23
ATE83663T1 (de) 1993-01-15
IL94459A (en) 1995-01-24
YU100790A (en) 1992-05-28
CA2017355A1 (fr) 1990-11-24
IE901821L (en) 1990-11-24
PT94139A (pt) 1991-01-08
IL94459A0 (en) 1991-03-10
AU5743390A (en) 1990-12-18
FR2647343A1 (fr) 1990-11-30
ZA903978B (en) 1991-03-27
AU5582890A (en) 1991-01-10
US5244881A (en) 1993-09-14
EP0399902A1 (fr) 1990-11-28
FI103712B (fi) 1999-08-31
ES2062437T3 (es) 1994-12-16
GR3006655T3 (ko) 1993-06-30
NZ233784A (en) 1993-04-28
FI103712B1 (fi) 1999-08-31
WO1990014089A1 (fr) 1990-11-29
ATE98867T1 (de) 1994-01-15
AU623779B2 (en) 1992-05-21
NO180517C (no) 1997-05-07
PT94138B (pt) 1996-12-31
NZ233766A (en) 1991-08-27
PT94138A (pt) 1991-01-08
EP0399902B1 (fr) 1993-12-22
IL94460A0 (en) 1991-03-10
KR0163423B1 (ko) 1998-12-01
IE901862L (en) 1990-11-24
NO902280L (no) 1990-11-26
DE69000641T2 (de) 1993-06-09
DE69005359D1 (de) 1994-02-03
EP0399903A1 (fr) 1990-11-28
ZA903895B (en) 1991-03-27
DE69000641D1 (de) 1993-02-04
FI902553A0 (fi) 1990-05-23
DK0399902T3 (da) 1994-02-14
AU631888B2 (en) 1992-12-10
IE64370B1 (en) 1995-07-26
CA2017360A1 (fr) 1990-11-24
PT94139B (pt) 1996-12-31
JPH0356412A (ja) 1991-03-12
DE69005359T2 (de) 1994-05-05
JP2948271B2 (ja) 1999-09-13

Similar Documents

Publication Publication Date Title
KR900017570A (ko) 신규한 다공성 제약학적 형태 및 그의 제조방법
ISHIDA et al. Mucosal dosage form of lidocaine for toothache using hydroxypropyl cellulose and carbopol
DZ1078A1 (fr) Formulation pharmaceutiques de substance labiles aux acides pour administration orale.
CA2044043A1 (en) Process for the production of rapidly disintegrating sheet-like presentations
KR850000975A (ko) 발프로익산과 그 염의 혼합물을 토대로 한 조성물
ES2185179T3 (es) Preparacion de composiciones farmaceuticas.
NZ501950A (en) Medicinal compositions for application to mucosa
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
EA200600528A1 (ru) Способ получения водорастворимых дитерпенов и их применение
ES460743A1 (es) Procedimiento para la obtencion de preparados medicinales con ph acido.
ATE424192T1 (de) Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten
KR880000095A (ko) 케토티펜 함유 약학적 조성물
NO870560L (no) Nytt farmasoeytisk preparat.
ATE290858T1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
ATE100095T1 (de) 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
OA07536A (fr) Nouveaux dérivés de la sulfonylurée, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
BE834590A (fr) Derives dipeptidiques, procede pour les preparer et compositions pharmaceutiques en content
ES8302454A1 (es) "un metodo para preparar una composicion solida y estable a base de un farmaco facilmente oxidable al aire".
BR9106272A (pt) Composicoes farmaceuticas contendo ipriflavona,processo para sua preparacao e uso terapeutico relativo
DE69624563D1 (de) Pharmazeutische zusammensetzung hergestellt durch zugabe eines geschmackstoff an einer wirkstoff
KR880003621A (ko) 의약 제제물
ES2174388T3 (es) Solucion liquida de medicamento para administracion oral.
ATE301452T1 (de) Verfahren zur herstellung einer flüssigen dosierungseinheit und kit
DE3673884D1 (de) Festes arzneimittel zur oralen verabreichung.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee